Services

Over the years, patent expirations, technological advancements, regulatory compliance. and unstable investor confidence have made the modern pharmaceutical industry an increasingly difficult and competitive environment, forcing the pharmaceutical industry to reorganize and rethink its drug development strategy.

 Aepodia provides an innovative approach in early clinical drug development from lead optimization up to Proof of Concept, based on client needs. We aim to help our clients avoiding costly late-stage clinical trials failures by improving results from early-phase clinical trials with faster and better GO/NO GO decisions.

Aepodia excels in optimizing Regulatory Strategy, guiding and representing the Sponsor in its interaction with American (FDA) and European regulatory agencies (EMA), or country-specific agencies.

On a daily basis, our staff interacts with Global Sponsors and Services Providers.